Jun 07, 2023 4:15 PM
Highlights for the First Quarter of Fiscal Year 2024
Results on a GAAP basis for the First Fiscal Quarter 2024
To facilitate a complete understanding of comparable financial performance between periods, the Company also presents performance results that exclude certain non-cash items and items that are not considered reflective of the Company’s core results over time. These non-GAAP financial measures exclude certain items and are described below under “Non-GAAP Financial Measures.”
Results on a Non-GAAP basis for the First Fiscal Quarter 2024 (see the list of non-GAAP financial measures and the reconciliation of these measures to the most comparable GAAP measures set forth in the tables below under "Supplemental Information: Reconciliation of GAAP to Non-GAAP Results")
“Semtech exceeded the midpoint of our revenue and earnings guidance as we see signs of business stabilization,” said
Second Fiscal Quarter 2024 Outlook
Both the GAAP and non-GAAP second fiscal quarter 2024 outlook below take into account, based on the Company's current estimates, export restrictions, inflationary pressure and other macroeconomic conditions. The Company is unable to predict the full impact such challenges may have on its future results of operations.
GAAP Second Fiscal Quarter 2024 Outlook
Non-GAAP Second Fiscal Quarter 2024 Outlook (see the list of non-GAAP financial measures and the reconciliation of Non-GAAP Gross margin, Non-GAAP SG&A expense, and Non-GAAP R&D expense to the most comparable GAAP measures set forth in the tables below under "Reconciliation of GAAP to Non-GAAP Outlook")
The Company is unable to include a reconciliation of the forward-looking non-GAAP normalized tax rate and non-GAAP Diluted loss per share to the corresponding GAAP measures as this is not available without unreasonable efforts due to the high variability and low visibility with respect to the impact of share-based awards and the amortization of acquisition-related intangible assets that are excluded from these non-GAAP measures. The Company expects the variability of the above charges to have a potentially significant impact on its GAAP financial results.
Webcast and Conference Call
Semtech will be hosting a conference call today to discuss its first fiscal quarter 2024 results at
Non-GAAP Financial Measures
To supplement the Company's consolidated financial statements prepared in accordance with GAAP, this release includes a presentation of select non-GAAP financial measures. The Company’s non-GAAP measures of gross margin, SG&A expense, R&D expense, operating margin, net (loss) income attributable to common stockholders, diluted (loss) earnings per share and normalized tax rate exclude the following items, if any:
To provide additional insight into the Company's second quarter outlook, this release also includes a presentation of forward-looking non-GAAP financial measures. Management believes that the presentation of these non-GAAP measures provides useful information to investors regarding the Company’s financial condition and results of operations. These non-GAAP financial measures are adjusted to exclude the items identified above because such items are either operating expenses that would not otherwise have been incurred by the Company in the normal course of the Company’s business operations, or are not reflective of the Company’s core results over time. These excluded items may include recurring as well as non-recurring items, and no inference should be made that all of these adjustments, charges, costs or expenses are unusual, infrequent or non-recurring. For example: certain restructuring and integration-related expenses (which consist of employee termination costs, facility closure or lease termination costs, and contract termination costs) may be considered recurring given the Company’s ongoing efforts to be more cost effective and efficient; certain acquisition and disposition-related adjustments or expenses may be deemed recurring given the Company's regular evaluation of potential transactions and investments; and certain litigation expenses or dispute settlement charges or gains (which may include estimated losses for which the Company may have established a reserve, as well as any actual settlements, judgments, or other resolutions against, or in favor of, the Company related to litigation, arbitration, disputes or similar matters, and insurance recoveries received by the Company related to such matters) may be viewed as recurring given that the Company may from time to time be involved in, and may resolve, litigation, arbitration, disputes, and similar matters.
Notwithstanding that certain adjustments, charges, costs or expenses may be considered recurring, in order to provide meaningful comparisons, the Company believes that it is appropriate to exclude such items because they are not reflective of the Company's core results and tend to vary based on timing, frequency and magnitude.
These non-GAAP financial measures are provided to enhance the user's overall understanding of the Company's comparable financial performance between periods. In addition, the Company’s management generally excludes the items noted above when managing and evaluating the performance of the business. The financial statements provided with this release include reconciliations of these non-GAAP financial measures to their most comparable GAAP measures for the first and fourth quarters of fiscal year 2023 and the first quarter of fiscal year 2024, along with a reconciliation of forward-looking non-GAAP measures (other than the non-GAAP normalized tax rate and non-GAAP Diluted (loss) earnings per share) to their most comparable GAAP measures for the second quarter of fiscal year 2024. The Company adopted a full-year, normalized tax rate for the computation of the non-GAAP income tax provision in order to provide better comparability across the interim reporting periods by reducing the quarterly variability in non-GAAP tax rates that can occur throughout the year. In estimating the full-year non-GAAP normalized tax rate, the Company utilized a full-year financial projection that considers multiple factors such as changes to the Company’s current operating structure, existing positions in various tax jurisdictions, the effect of key tax law changes, and other significant tax matters to the extent they are applicable to the full fiscal year financial projection. In addition to the adjustments described above, this normalized tax rate excludes the impact of share-based awards and the amortization of acquisition-related intangible assets. For fiscal year 2024, the Company’s projected non-GAAP normalized tax rate is 12% and will be applied to each quarter of fiscal year 2024. The Company’s non-GAAP normalized tax rate on non-GAAP net income may be adjusted during the year to account for events or trends that the Company believes materially impact the original annual non-GAAP normalized tax rate including, but not limited to, significant changes resulting from tax legislation, acquisitions, entity structures or operational changes and other significant events. These additional non-GAAP financial measures should not be considered substitutes for any measures derived in accordance with GAAP and may be inconsistent with similar measures presented by other companies.
Forward-Looking and Cautionary Statements
This press release contains "forward-looking statements" within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, as amended, based on the Company’s current expectations, estimates and projections about its operations, industry, financial condition, performance, results of operations, and liquidity. Forward-looking statements are statements other than historical information or statements of current condition and relate to matters such as future financial performance including the second quarter of fiscal year 2024 outlook; the Company’s expectations concerning the negative impact on the Company’s results of operations from export restrictions, inflationary pressure and other macroeconomic conditions; future operational performance; the anticipated impact of specific items on future earnings; and the Company’s plans, objectives and expectations. Statements containing words such as “may,” “believes,” “anticipates,” “expects,” “intends,” “plans,” “projects,” “estimates,” “should,” “will,” “designed to,” “projections,” or “business outlook,” or other similar expressions constitute forward-looking statements.
Forward-looking statements involve known and unknown risks and uncertainties that could cause actual results and events to differ materially from those projected. Potential factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: the inherent risks, costs and uncertainties associated with integrating
About Semtech
Semtech and the Semtech logo are registered trademarks or service marks of
SMTC-F
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (in thousands, except per share data) (unaudited) |
|||||||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q124 |
|
Q423 |
|
Q123 |
||||||
Net sales |
$ |
236,539 |
|
|
$ |
167,512 |
|
|
$ |
202,149 |
|
Cost of sales |
|
122,738 |
|
|
|
64,934 |
|
|
|
71,896 |
|
Amortization of acquired technology |
|
10,855 |
|
|
|
2,565 |
|
|
|
1,048 |
|
Total cost of sales |
|
133,593 |
|
|
|
67,499 |
|
|
|
72,944 |
|
Gross profit |
|
102,946 |
|
|
|
100,013 |
|
|
|
129,205 |
|
Operating costs and expenses, net: |
|
|
|
|
|
||||||
Selling, general and administrative |
|
58,117 |
|
|
|
101,952 |
|
|
|
43,364 |
|
Product development and engineering |
|
51,827 |
|
|
|
52,899 |
|
|
|
38,789 |
|
Intangible amortization |
|
4,882 |
|
|
|
821 |
|
|
|
— |
|
Total operating costs and expenses, net |
|
114,826 |
|
|
|
155,672 |
|
|
|
82,153 |
|
Operating (loss) income |
|
(11,880 |
) |
|
|
(55,659 |
) |
|
|
47,052 |
|
Interest expense |
|
(20,510 |
) |
|
|
(6,181 |
) |
|
|
(1,197 |
) |
Interest income |
|
1,069 |
|
|
|
4,043 |
|
|
|
364 |
|
Non-operating expense, net |
|
(473 |
) |
|
|
(735 |
) |
|
|
(102 |
) |
Investment impairments and credit loss reserves, net |
|
(33 |
) |
|
|
(1,532 |
) |
|
|
(24 |
) |
(Loss) income before taxes and equity method (loss) income |
|
(31,827 |
) |
|
|
(60,064 |
) |
|
|
46,093 |
|
(Benefit) provision for taxes |
|
(2,417 |
) |
|
|
(9,071 |
) |
|
|
8,069 |
|
Net (loss) income before equity method (loss) income |
|
(29,410 |
) |
|
|
(50,993 |
) |
|
|
38,024 |
|
Equity method (loss) income |
|
(7 |
) |
|
|
(22 |
) |
|
|
24 |
|
Net (loss) income |
|
(29,417 |
) |
|
|
(51,015 |
) |
|
|
38,048 |
|
Net loss attributable to noncontrolling interest |
|
(2 |
) |
|
|
(2 |
) |
|
|
(1 |
) |
Net (loss) income attributable to common stockholders |
$ |
(29,415 |
) |
|
$ |
(51,013 |
) |
|
$ |
38,049 |
|
|
|
|
|
|
|
||||||
(Loss) earnings per share: |
|
|
|
|
|
||||||
Basic |
$ |
(0.46 |
) |
|
$ |
(0.80 |
) |
|
$ |
0.59 |
|
Diluted |
$ |
(0.46 |
) |
|
$ |
(0.80 |
) |
|
$ |
0.59 |
|
|
|
|
|
|
|
||||||
Weighted average number of shares used in computing (loss) earnings per share: |
|
|
|
|
|
||||||
Basic |
|
63,924 |
|
|
|
63,864 |
|
|
|
63,950 |
|
Diluted |
|
63,924 |
|
|
|
63,924 |
|
|
|
64,553 |
|
CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) (unaudited) |
|||||
|
|
|
|
||
ASSETS |
|
|
|
||
Current assets: |
|
|
|
||
Cash and cash equivalents |
$ |
164,198 |
|
$ |
235,510 |
Accounts receivable, net |
|
145,383 |
|
|
161,695 |
Inventories |
|
213,234 |
|
|
207,704 |
Prepaid taxes |
|
11,554 |
|
|
6,243 |
Other current assets |
|
130,030 |
|
|
111,634 |
Total current assets |
|
664,399 |
|
|
722,786 |
Non-current assets: |
|
|
|
||
Property, plant and equipment, net |
|
165,341 |
|
|
169,293 |
Deferred tax assets |
|
67,490 |
|
|
63,783 |
|
|
1,288,828 |
|
|
1,281,703 |
Other intangible assets, net |
|
198,784 |
|
|
215,102 |
Other assets |
|
115,182 |
|
|
116,961 |
Total assets |
$ |
2,500,024 |
|
$ |
2,569,628 |
|
|
|
|
||
LIABILITIES AND EQUITY |
|
|
|
||
Current liabilities: |
|
|
|
||
Accounts payable |
$ |
74,407 |
|
$ |
100,676 |
Accrued liabilities |
|
192,654 |
|
|
253,075 |
Current portion of long-term debt |
|
42,695 |
|
|
43,104 |
Total current liabilities |
|
309,756 |
|
|
396,855 |
Non-current liabilities: |
|
|
|
||
Deferred tax liabilities |
|
4,708 |
|
|
5,065 |
Long-term debt |
|
1,336,636 |
|
|
1,296,966 |
Other long-term liabilities |
|
115,715 |
|
|
114,707 |
Stockholders’ equity |
|
733,028 |
|
|
755,852 |
Noncontrolling interest |
|
181 |
|
|
183 |
Total liabilities & equity |
$ |
2,500,024 |
|
$ |
2,569,628 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS AND SUPPLEMENTAL INFORMATION (in thousands) (unaudited) |
|||||||||||
|
|
|
Three Months Ended |
||||||||
|
|
|
|
|
|
||||||
Net (loss) income |
|
|
$ |
(29,417 |
) |
|
$ |
38,048 |
|
||
|
|
|
|
|
|
||||||
Net cash (used in) provided by operations |
|
|
|
(89,987 |
) |
|
|
50,051 |
|
||
Net cash used in investing activities |
|
|
|
(14,407 |
) |
|
|
(10,315 |
) |
||
Net cash provided by (used in) financing activities |
|
|
|
33,728 |
|
|
|
(44,153 |
) |
||
Effect of foreign exchange rate changes on cash and cash equivalents |
|
|
|
(646 |
) |
|
|
— |
|
||
Net decrease in cash and cash equivalents |
|
|
|
(71,312 |
) |
|
|
(4,417 |
) |
||
Cash and cash equivalents at beginning of period |
|
|
|
235,510 |
|
|
|
279,601 |
|
||
Cash and cash equivalents at end of period |
|
|
$ |
164,198 |
|
|
$ |
275,184 |
|
||
|
|
|
|
|
|
||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q124 |
|
Q423 |
|
Q123 |
||||||
Free Cash Flow: |
|
|
|
|
|
||||||
Cash Flow from Operations |
$ |
(89,987 |
) |
|
$ |
(18,799 |
) |
|
$ |
50,051 |
|
Net Capital Expenditures |
|
(13,977 |
) |
|
|
(5,680 |
) |
|
|
(8,315 |
) |
Free Cash Flow |
$ |
(103,964 |
) |
|
$ |
(24,479 |
) |
|
$ |
41,736 |
|
|
Three Months Ended |
||||
(in thousands) |
|
||||
Net sales by reportable segment: |
|
|
|
||
|
$ |
41,646 |
|
18 |
% |
|
|
36,057 |
|
15 |
% |
|
|
134,576 |
|
57 |
% |
|
|
24,260 |
|
10 |
% |
Total net sales by reportable segment |
$ |
236,539 |
|
100 |
% |
|
Three Months Ended |
||||
(in thousands) |
|
||||
Net sales by end market: |
|
|
|
||
Infrastructure |
$ |
39,000 |
|
16 |
% |
High-End Consumer |
|
21,594 |
|
9 |
% |
Industrial |
|
175,945 |
|
75 |
% |
Total net sales by end market |
$ |
236,539 |
|
100 |
% |
SUPPLEMENTAL INFORMATION: RECONCILIATION OF GAAP TO NON-GAAP RESULTS (in thousands, except per share data) (unaudited) |
|||||||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q124 |
|
Q423 |
|
Q123 |
||||||
Gross Margin–GAAP |
|
43.5 |
% |
|
|
59.7 |
% |
|
|
63.9 |
% |
Share-based compensation |
|
0.2 |
% |
|
|
0.4 |
% |
|
|
0.4 |
% |
Amortization of acquired technology |
|
4.6 |
% |
|
|
1.5 |
% |
|
|
0.5 |
% |
Share-based compensation acceleration expense |
|
— |
% |
|
|
0.5 |
% |
|
|
— |
% |
Restructuring and other reserves |
|
0.2 |
% |
|
|
0.2 |
% |
|
|
— |
% |
Adjusted Gross Margin (Non-GAAP) |
|
48.5 |
% |
|
|
62.3 |
% |
|
|
64.8 |
% |
|
|
|
|
|
|
||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q124 |
|
Q423 |
|
Q123 |
||||||
Selling, general and administrative–GAAP |
$ |
58,117 |
|
|
$ |
101,952 |
|
|
$ |
43,364 |
|
Share-based compensation |
|
(4,502 |
) |
|
|
(7,801 |
) |
|
|
(6,132 |
) |
Transaction and integration related costs, net |
|
(7,068 |
) |
|
|
(22,513 |
) |
|
|
(495 |
) |
Share-based compensation acceleration expense |
|
— |
|
|
|
(33,937 |
) |
|
|
— |
|
Restructuring and other reserves, net |
|
(337 |
) |
|
|
(8,850 |
) |
|
|
(500 |
) |
Litigation costs, net |
|
(26 |
) |
|
|
(13 |
) |
|
|
(181 |
) |
Adjusted selling, general and administrative (Non-GAAP) |
$ |
46,184 |
|
|
$ |
28,838 |
|
|
$ |
36,056 |
|
|
|
|
|
|
|
||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q124 |
|
Q423 |
|
Q123 |
||||||
Product development and engineering–GAAP |
$ |
51,827 |
|
|
$ |
52,899 |
|
|
$ |
38,789 |
|
Share-based compensation |
|
(3,539 |
) |
|
|
(3,592 |
) |
|
|
(3,986 |
) |
Transaction and integration related costs, net |
|
(534 |
) |
|
|
(25 |
) |
|
|
— |
|
Share-based compensation acceleration expense |
|
— |
|
|
|
(11,010 |
) |
|
|
— |
|
Restructuring and other reserves, net |
|
(1,226 |
) |
|
|
(397 |
) |
|
|
— |
|
Adjusted product development and engineering (Non-GAAP) |
$ |
46,528 |
|
|
$ |
37,875 |
|
|
$ |
34,803 |
|
|
|
|
|
|
|
||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q124 |
|
Q423 |
|
Q123 |
||||||
Operating Margin–GAAP |
|
(5.0 |
)% |
|
|
(33.2 |
)% |
|
|
23.3 |
% |
Share-based compensation |
|
3.6 |
% |
|
|
7.2 |
% |
|
|
5.5 |
% |
Intangible amortization |
|
6.6 |
% |
|
|
2.0 |
% |
|
|
0.5 |
% |
Transaction and integration related costs, net |
|
3.2 |
% |
|
|
13.5 |
% |
|
|
0.2 |
% |
Share-based compensation acceleration expense |
|
— |
% |
|
|
27.3 |
% |
|
|
— |
% |
Restructuring and other reserves, net |
|
0.9 |
% |
|
|
5.7 |
% |
|
|
0.2 |
% |
Litigation costs, net |
|
— |
% |
|
|
— |
% |
|
|
0.1 |
% |
Adjusted Operating Margin (Non-GAAP) |
|
9.3 |
% |
|
|
22.5 |
% |
|
|
29.8 |
% |
SUPPLEMENTAL INFORMATION: RECONCILIATION OF GAAP TO NON-GAAP RESULTS (CONTINUED) (in thousands, except per share data) (unaudited) |
|||||||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q124 |
|
Q423 |
|
Q123 |
||||||
GAAP net (loss) income attributable to common stockholders |
$ |
(29,415 |
) |
|
$ |
(51,013 |
) |
|
$ |
38,049 |
|
Adjustments to GAAP net (loss) income attributable to common stockholders: |
|
|
|
|
|
||||||
Share-based compensation |
|
8,404 |
|
|
|
12,020 |
|
|
|
10,893 |
|
Intangible amortization |
|
15,737 |
|
|
|
3,386 |
|
|
|
1,048 |
|
Transaction and integration related costs, net |
|
7,651 |
|
|
|
22,642 |
|
|
|
495 |
|
Share-based compensation acceleration expense |
|
— |
|
|
|
45,749 |
|
|
|
— |
|
Restructuring and other reserves |
|
2,060 |
|
|
|
9,536 |
|
|
|
500 |
|
Litigation costs, net |
|
26 |
|
|
|
13 |
|
|
|
181 |
|
Investment (gains) losses, reserves and impairments, net |
|
(317 |
) |
|
|
1,190 |
|
|
|
(324 |
) |
Total Non-GAAP adjustments before taxes |
|
33,561 |
|
|
|
94,536 |
|
|
|
12,793 |
|
Associated tax effect |
|
(2,625 |
) |
|
|
(13,208 |
) |
|
|
1,003 |
|
Equity method loss (income) |
|
7 |
|
|
|
22 |
|
|
|
(24 |
) |
Total of supplemental information, net of taxes |
|
30,943 |
|
|
|
81,350 |
|
|
|
13,772 |
|
Non-GAAP net income attributable to common stockholders |
$ |
1,528 |
|
|
$ |
30,337 |
|
|
$ |
51,821 |
|
|
|
|
|
|
|
||||||
GAAP diluted (loss) earnings per share |
$ |
(0.46 |
) |
|
$ |
(0.80 |
) |
|
$ |
0.59 |
|
Adjustments per above |
|
0.48 |
|
|
|
1.27 |
|
|
|
0.21 |
|
Non-GAAP diluted earnings per share |
$ |
0.02 |
|
|
$ |
0.47 |
|
|
$ |
0.80 |
|
RECONCILIATION OF GAAP TO NON-GAAP OUTLOOK Second Quarter of Fiscal Year 2024 Outlook (in millions, except per share data) |
||||||||
|
|
Q2 FY24 Outlook |
||||||
|
|
|
||||||
|
|
Low |
|
High |
||||
Gross Margin–GAAP |
|
|
42.6 |
% |
|
|
44.8 |
% |
Share-based compensation |
|
|
0.2 |
% |
|
|
0.2 |
% |
Amortization of acquired intangibles |
|
|
4.7 |
% |
|
|
4.5 |
% |
Adjusted Gross Margin (Non-GAAP) |
|
|
47.5 |
% |
|
|
49.5 |
% |
|
|
|
|
|
||||
|
|
Low |
|
High |
||||
Selling, general and administrative–GAAP |
|
$ |
63.2 |
|
|
$ |
65.2 |
|
Share-based compensation |
|
|
(8.2 |
) |
|
|
(8.2 |
) |
Transaction and integration related |
|
|
(10.0 |
) |
|
|
(10.0 |
) |
Adjusted selling, general and administrative (Non-GAAP) |
|
$ |
45.0 |
|
|
$ |
47.0 |
|
|
|
|
|
|
||||
|
|
Low |
|
High |
||||
Product development and engineering–GAAP |
|
$ |
48.0 |
|
|
$ |
50.0 |
|
Share-based compensation |
|
|
(4.0 |
) |
|
|
(4.0 |
) |
Adjusted product development and engineering (Non-GAAP) |
|
$ |
44.0 |
|
|
$ |
46.0 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20230607005732/en/
(630) 390-6413
Anojja.Shah@semtech.com
Source: